Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty

被引:144
作者
Innerhofer, P
Klingler, A
Klimmer, C
Fries, D
Nussbaumer, W
机构
[1] Univ Innsbruck, Dept Anesthesia Crit Care Med, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Theoret Surg Unit, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria
[3] Univ Innsbruck, Dept Transfus Med, A-6020 Innsbruck, Austria
关键词
D O I
10.1111/j.1537-2995.2005.04149.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: This study was designed to obtain data on the incidence of postoperative infection in patients undergoing elective orthopedic surgery and receiving white blood cell (WBC)-filtered blood components prepared according to current standards. STUDY DESIGN AND METHODS: A total of 308 consecutive orthopedic patients who opted for preoperative autologous blood donation (PAD) for primary unilateral hip and knee replacement surgery were enrolled in a prospective observational study of the incidence of postoperative infection. Patients with contraindications for PAD or with any infectious disease were not included in the study. To identify probably confounding factors, differences between patient groups were analyzed first. Identified factors, which differed between groups, and variables describing blood supply were further tested in uni- and multivariate logistic regression analysis for their independent influence on development of postoperative infection. Infection rates were compared on the basis of actual transfusion groups. RESULTS: Of the 308 study patients, 101 were not transfused, 85 received their PAD, 100 received allogeneic WBC-filtered red blood cells (RBCs), and 22 were given autologous RBCs and additionally allogeneic WBC-filtered RBCs. Overall the infection rate was 6.82 percent (21/308). Infection rates varied significantly between transfusion groups (no transfusion, 6.9%; autologous RBCs, 1.2%; allogeneic WBC-filtered RBCs, 12.0%; both transfusion types, 4.6%; p = 0.03). Allogeneic recipients showed significantly more infections compared to autologous recipients (p = 0.0053). Multivariate regression analysis confirmed transfusion of allogeneic WBC-filtered RBCs as an independent variable predicting postoperative infection (odds ratio, 23.65; confidence interval, 1.3-422.1; p = 0.01). CONCLUSION: Differences in postoperative infection rates between allogeneic and autologous recipients are still observable, although universal WBC filtration has been introduced into clinical practice.
引用
收藏
页码:103 / 110
页数:8
相关论文
共 23 条
[1]   Red blood cells as modulators of T cell growth and survival [J].
Arosa, FA ;
Pereira, CF ;
Fonseca, AM .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (02) :191-201
[2]   The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery [J].
Baron, JF ;
Gourdin, M ;
Bertrand, M ;
Mercadier, A ;
Delort, J ;
Kieffer, E ;
Coriat, P .
ANESTHESIA AND ANALGESIA, 2002, 94 (03) :529-537
[3]   Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? [J].
Blajchman, MA .
TRANSFUSION, 1999, 39 (07) :665-670
[4]   Immunomodulation by blood transfusion: An evolving scientific and clinical challenge [J].
Blumberg, N ;
Heal, JM .
AMERICAN JOURNAL OF MEDICINE, 1996, 101 (03) :299-308
[5]   Leukoreduction of blood components [J].
Dzik, WH .
CURRENT OPINION IN HEMATOLOGY, 2002, 9 (06) :521-526
[6]   A prospective, randomized clinical trial of universal WBC reduction [J].
Dzik, WH ;
Anderson, JK ;
O'Neill, EM ;
Assmann, SF ;
Kalish, LA ;
Stowell, CP .
TRANSFUSION, 2002, 42 (09) :1114-1122
[7]   Modulation of immune response by blood transfusion: Evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery [J].
Heiss, MM ;
Fraunberger, P ;
Delanoff, C ;
Stets, R ;
Allgayer, H ;
Strohlein, MA ;
Tarabichi, A ;
Faist, E ;
Jauch, KW ;
Schildberg, FW .
SHOCK, 1997, 8 (06) :402-408
[8]   BENEFICIAL EFFECT OF AUTOLOGOUS BLOOD-TRANSFUSION ON INFECTIOUS COMPLICATIONS AFTER COLORECTAL-CANCER SURGERY [J].
HEISS, MM ;
MEMPEL, W ;
JAUCH, KW ;
DELANOFF, C ;
MAYER, G ;
MEMPEL, M ;
EISSNER, HJ ;
SCHILDBERG, FW .
LANCET, 1993, 342 (8883) :1328-1333
[9]   RANDOMIZED CONTROLLED TRIAL COMPARING TRANSFUSION OF LEUKOCYTE-DEPLETED OR BUFFY-COAT-DEPLETED BLOOD IN SURGERY FOR COLORECTAL-CANCER [J].
HOUBIERS, JGA ;
BRAND, A ;
VANDEWATERING, LMG ;
HERMANS, J ;
VERWEY, PJM ;
BIJNEN, AB ;
PAHLPLATZ, P ;
SCHATTENKERK, ME ;
WOBBES, T ;
DEVRIES, JE ;
KLEMENTSCHITSCH, P ;
VANDEMAAS, AHM ;
VANDEVELDE, CJH .
LANCET, 1994, 344 (8922) :573-578
[10]   Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T cells, macrophages, and cell-mediated lympholysis [J].
Innerhofer, P ;
Tilz, G ;
Fuchs, D ;
Luz, G ;
Hobisch-Hagen, P ;
Schobersberger, W ;
Nussbaumer, W ;
Lochs, A ;
Irschick, E .
TRANSFUSION, 2000, 40 (07) :821-827